Klinische Studien in Gießen

In Gießen (Hessen) rekrutieren 120 klinische Studien an 121 Standorten.

StudiePhaseStatus
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-796Phase IIIrekrutiert
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line TreaPhase IIIrekrutiert
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line TreaPhase IIIrekrutiert
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent ChemoradiPhase IIIrekrutiert
A Long-term Extension Study of PCI-32765 (Ibrutinib)Phase IIIrekrutiert
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerekrutiert
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisPhase IIrekrutiert
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants WithPhase IIIrekrutiert
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in PrevPhase IIIrekrutiert
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILDPhase IIIrekrutiert
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.Phase IIrekrutiert
A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type CPhase IIIrekrutiert
A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobrekrutiert
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early InterventiPhase IVrekrutiert
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients Phase IVrekrutiert
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus ChPhase IIIrekrutiert
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in PPhase IIIrekrutiert
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally AdvancPhase IIIrekrutiert
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With RelapsePhase IIIrekrutiert
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung CancerPhase Irekrutiert
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men Phase IIIrekrutiert
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and NewbPhase IIIrekrutiert
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Phase IIIrekrutiert
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants WiPhase IIIrekrutiert
A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPrekrutiert
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal GrowPhase IIrekrutiert
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registryrekrutiert
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Phase IIIrekrutiert
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among HospPhase IIIrekrutiert
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple ScPhase IIIrekrutiert
A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/MiglPhase IIIrekrutiert
A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levelrekrutiert
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared Phase IIIrekrutiert
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary ArterialPhase IIrekrutiert
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in AdultPhase IIIrekrutiert
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in ParticipantsPhase I / Phase IIrekrutiert
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With StanPhase IIIrekrutiert
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, ThPhase IIIrekrutiert
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With StandarPhase IIIrekrutiert
A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in ChildPhase IIIrekrutiert
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1Phase IIrekrutiert
Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-CellPhase IIIrekrutiert
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaPhase II / Phase IIIrekrutiert
An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defectsrekrutiert
An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medicalrekrutiert
Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancerohne Phasenangaberekrutiert
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With Phase IIrekrutiert
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatmentrekrutiert
Brain Signal Training to Enhance Affect Down-regulationPhase I / Phase IIrekrutiert
CEDATA GPGE - a Patient Registry for Children and Adolescents With Inflammatory Bowel Diseaserekrutiert
COMPERA / COMPERA-KIDSrekrutiert
COVID-19 Vaccines Safety Tracking (CoVaST)rekrutiert
Changes in Sensitivity, Taste and Smell in Stroke Patientsrekrutiert
Cohort Study on Plant-based Diets (COPLANT Study)rekrutiert
Comparison of Optical Coherence Tomography-derived Minimal Lumen Area, Invasive Fractional Flow ohne Phasenangaberekrutiert
Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenosesohne Phasenangaberekrutiert
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Womenohne Phasenangaberekrutiert
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMIohne Phasenangaberekrutiert
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidorekrutiert
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive PulmonPhase IIIrekrutiert
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With EmpaglPhase IIIrekrutiert
Endometrial Cancer Lymphadenectomy Trialohne Phasenangaberekrutiert
European Disease Registry on Retinopathy of Prematurity (ROP)rekrutiert
Fabry Disease Registry & Pregnancy Sub-registryrekrutiert
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASPhase IIIrekrutiert
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Trekrutiert
GMMG Multiple Myeloma Registryrekrutiert
Giessen Pulmonary Hypertension Registry and Biobankrekrutiert
Giessen Pulmonary Hypertension in Lung Cancer Registryrekrutiert
Giessen Stroke Registryrekrutiert
IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid TumorsPhase I / Phase IIrekrutiert
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MELPhase IIIrekrutiert
Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLCPhase IIrekrutiert
Impact of Beta-blocker on Outcome Among Patients Undergoing Transcatheter Aortic Valve Replacemeohne Phasenangaberekrutiert
Improved Management of Patients With Recent-Onset Stable Chest Painohne Phasenangaberekrutiert
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed PhenPhase IIIrekrutiert
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registrekrutiert
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic LymPhase IIIrekrutiert
International HIT-MED Registry (I-HIT-MED)rekrutiert
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCPhase IIIrekrutiert
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCPhase IIIrekrutiert
Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Follorekrutiert
MiCLASP Post Market Clinical Follow-Up (PMCF) Studyrekrutiert
Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescrekrutiert
Multidimensional Assessment of Infant, Parent and Staff Outcomes During a Family Centered Care Erekrutiert
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in APhase IIIrekrutiert
Nivolumab in Children and Adults With Nasopharyngeal CarcinomaPhase IIrekrutiert
Non-invasive Measurement of the Hypotension Prediction Index for the Reduction of Intraoperativeohne Phasenangaberekrutiert
OP2C : Prialt® Observatory in Clinical Practicerekrutiert
One-Month DAPT in CABG PatientsPhase IIIrekrutiert
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)Phase IIIrekrutiert
PROCARE - PROstate Cancer Real World Evidence Registryrekrutiert
PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes andrekrutiert
PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertensionrekrutiert
Perioperative Interdisciplinary, Intersectoral Process Optimization in Heart Failureohne Phasenangaberekrutiert
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 TrialPhase II / Phase IIIrekrutiert
Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDPhase IIrekrutiert
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With NewPhase IIIrekrutiert
Pompe Disease Registry Protocolrekrutiert
Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORPhase IIIrekrutiert
Proton vs. Photon Radiotherapy for Patients With WHO Grade 2-3 Gliomaohne Phasenangaberekrutiert
Pulmonary Hemodynamics During Exercise - Research Networkrekrutiert
Quality Improvement Project to Reduce Preoperative Fasting Times Before Elective Proceduresrekrutiert
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fracturesohne Phasenangaberekrutiert
Randomization of Single vs Multiple Arterial Graftsohne Phasenangaberekrutiert
Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Arteryohne Phasenangaberekrutiert
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-Phase IIIrekrutiert
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Studyrekrutiert
Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years Wirekrutiert
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acrekrutiert
Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct OralPhase IVrekrutiert
Sequelae of Sars-CoV-2 Infectionsrekrutiert
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapyrekrutiert
Study of Organ Perfusion in Heart Transplantation in ChildrenPhase IIrekrutiert
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERIONPhase IIIrekrutiert
Therapy Optimisation for the Treatment of Hairy Cell LeukemiaPhase II / Phase IIIrekrutiert
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin PluPhase IIIrekrutiert
Topical Application of PRF Before Radiation Therapyohne Phasenangaberekrutiert
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALPhase IIIrekrutiert
Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectableohne Phasenangaberekrutiert

Wir fragen für Sie nach

Drei Fragen, dann fragen wir bei den Prüfzentren in Ihrer Nähe nach, ob eine passende Studie Teilnehmer aufnimmt. Kostenlos und unverbindlich.

Kostenlos und unverbindlich. Wir beraten nicht und empfehlen keine Studie.

Diese Seite ersetzt kein ärztliches Gespräch. Ob eine Studie für Sie infrage kommt, entscheidet allein das Prüfzentrum nach einem Aufklärungsgespräch und einer Eignungsprüfung. Wir bewerten keine Studie, empfehlen keine Behandlung und stehen in keinem Verhältnis zu den Sponsoren.

Orte in der Nähe

Datenstand: 2026-08-12. Quelle: ClinicalTrials.gov, U.S. National Library of Medicine — gemeinfrei. Der Stand ist der des Abrufs; Studien öffnen und schließen laufend.